The Safety and Effectiveness of Interleukin-2 Plus Zidovudine in Patients With AIDS or AIDS Related Complex

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

Not specified

Study Completion Date

January 31, 1994

Conditions
HIV Infections
Interventions
DRUG

Zidovudine

DRUG

Aldesleukin

Trial Locations (1)

Unknown

Univ of Pittsburgh Med School, Pittsburgh

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH